HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis.

Abstract
The sera of six patients with autoimmune disease, predominantly myositis with pulmonary fibrosis, contain antibodies of the PL-12 specificity. These autoantibodies react with both protein and RNA components of human cells. The protein has a subunit molecular mass of 110 kD, and the RNA comprises a group of bands in the tRNA size class. Aminoacylation experiments identify the antigens as alanyl-tRNA synthetase and its corresponding tRNAs, tRNAAla. Anti-tRNA antibody can be absorbed out without depleting antisynthetase activity, showing that the antigens are recognized independently by separable antibodies that coexist in these sera. The concurrence of separate antibodies to the two components suggests that the autoimmune response may be mounted against the charging enzyme-tRNA complex. However, the antisynthetase antibody fails to coprecipitate tRNA with the enzyme, suggesting that the antibody reacts with its target only when it is not complexed with tRNA.
AuthorsC C Bunn, R M Bernstein, M B Mathews
JournalThe Journal of experimental medicine (J Exp Med) Vol. 163 Issue 5 Pg. 1281-91 (May 01 1986) ISSN: 0022-1007 [Print] United States
PMID3701255 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • RNA, Transfer
  • Amino Acyl-tRNA Synthetases
  • Alanine-tRNA Ligase
  • Alanine
Topics
  • Adult
  • Alanine
  • Alanine-tRNA Ligase (antagonists & inhibitors, immunology)
  • Amino Acyl-tRNA Synthetases (immunology)
  • Antibody Specificity
  • Autoantibodies (immunology)
  • Autoimmune Diseases (immunology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myositis (immunology)
  • RNA, Transfer (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: